LG Life Sciences sues domestic drug makers

Published: 2007-08-27 06:58:00

Updated: 2007-08-27 06:58:00

LG Life Sciences said on August 23 that it is suing local pharmaceutical companies for violating its patent right of Zanidip (lercanidipine HCl), a calcium channel blocker.

Calcium channel blockers are widely used for the treatment of systemic arterial hypertension. All the drugs in this class...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK